Leap Therapeutics raises $58.9M in PIPE led by Winklevoss Capital, adopts digital asset treasury strategy

CYPHERPUNK TECHNOLOGIES INC.

$58,888,888 in cash commitments for PIPE offering at $0.61439 per unit, led by Winklevoss Capital.
Issues 95.8M shares/pre-funded warrants and 71.9M warrants exercisable at $0.5335 per share.
Closing expected October 8, 2025; Winklevoss Capital to nominate two board members, one as chair.
Proceeds to fund digital asset treasury strategy and continued development of FL-501 and sirexatamab.
Company reaffirms pursuit of existing biotech pipeline alongside new digital asset strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.